Millions of lives are set to be changed for the better thanks to a landmark deal between Griffith University and Swiss-based company LimmaTech Biologics AG to develop a world-first gonorrhoea vaccine.
We are delighted to share some successful outcomes for NHMRC Investigator Fellowships announced on 12 October 2022 by the National Health and Medical Research Council (NHMRC).
Griffith University’s Institute for Glycomics celebrates the promotion of six of its researchers, in recognition of their outstanding contributions to research. Associate Professor Kate Seib, Research Leader at the Institute for Glycomics, has been promoted to Professor. “I am very excited about this promotion, and so grateful to my team, my collaborators and my mentors […]
Key Griffith University research projects have received $4.5 million in funding from the National Health and Medical Research Council. Announced on December 15 by the Federal Minister for Health, The Honorable Greg Hunt MP, the seven Ideas Grants projects will contribute to vital health and medical research. Deputy Vice Chancellor (Research) Professor Mario Pinto said […]
Griffith University’s Institute for Glycomics has been awarded $2.66 million in Ideas Grant funding from the National Health and Medical Research Council (NHMRC) to aid four vital research projects. Director Professor Mark von Itzstein AO was delighted with the grant awards and said they cemented the Institute’s reputation as a leading biomedical research institute. “Our […]
A research project by Griffith University’s Institute for Glycomics seeks to identify and develop new drugs and a vaccine to protect against antibiotic-resistant gonorrhoea. The bacteria Neisseria gonorrhoeae (Ng) causes the sexually transmitted infection gonorrhoea, which has significant impact on global health, infecting more than 100 million people each year. “In 2018, ‘super gonorrhoea’, resistant […]
A world-first trial for a promising gonorrhoea vaccine will be led by Griffith University’s Institute for Glycomics and the Kirby Institute at UNSW Sydney. The $2.7 million study incorporates five Australian universities and three health districts and providers, and will test whether a meningococcal B vaccine protects against gonorrhoea in gay and bisexual men. “Gonorrhoea […]